Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

taVNS reduces vitiligo symptoms in mice.

ILC1-like cells can cause alopecia areata by themselves.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Lack of Evi in skin causes psoriasis-like symptoms in mice.

UV exposure harms skin by causing fibroblast loss, but T cells help fibroblast survival.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

IL-27 can prevent hair loss in alopecia areata.

The gut microbiome affects the development of alopecia areata.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Tick bites cause skin damage and long-lasting reactions.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.